West Pharmaceutical Services, Inc.
WST
$302.40
-$9.67-3.10%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.57% | 1.54% | 2.94% | 18.42% | -22.12% |
| Total Depreciation and Amortization | 13.00% | 15.48% | 6.97% | 6.43% | 12.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,860.00% | -130.95% | 202.50% | 1,042.86% | -126.32% |
| Change in Net Operating Assets | -103,000.00% | 247.66% | 2,200.00% | -129.08% | 100.29% |
| Cash from Operations | -30.53% | 32.09% | 9.49% | 7.33% | 9.48% |
| Capital Expenditure | 40.11% | 27.45% | 22.14% | 24.95% | 21.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 40.11% | 27.39% | 22.90% | 25.69% | 21.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | -200.00% | 99.77% | 99.49% | 71.43% |
| Issuance of Common Stock | 70.45% | 48.39% | -33.33% | -23.53% | -73.81% |
| Repurchase of Common Stock | -120.66% | 99.63% | 99.81% | 99.73% | 50.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.95% | -3.27% | -4.14% | -3.42% | -3.40% |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -110.00% | 83.02% | 82.14% | 93.17% | 45.76% |
| Foreign Exchange rate Adjustments | -198.82% | 97.80% | -132.43% | 1,781.82% | 197.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -235.70% | 2,684.13% | 165.77% | 167.80% | 68.11% |